Navigation Links
Pivotal Phase III Data Confirm the Efficacy and Safety of Arpida's Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections
Date:10/26/2008

Iclaprim also achieved high eradication rates for the most common pathogens, including methicillin-resistant Staphylococcus aureus (MRSA)

REINACH, Switzerland, Oct. 26 /PRNewswire-FirstCall/ -- Arpida (SWX: ARPN) today presented the combined results from two pivotal Phase III clinical trials at the 48th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)/Infectious Diseases Society of America (IDSA) 46th annual meeting in Washington, DC. In these studies, intravenous iclaprim, a novel antibiotic, showed high clinical cure rates which were similar to those of the comparator drug, linezolid, in the treatment of complicated skin and skin structure infections (cSSSI) caused by Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). In addition, iclaprim was well-tolerated with a safety profile that compared favorably to linezolid. A New Drug Application for intravenous iclaprim in cSSSI will be discussed at the meeting of the U.S. Food and Drug Administration Anti-Infective Drugs Advisory Committee on 20 November 2008.

Iclaprim, a novel antibiotic from the trusted dihydrofolate reductase (DHFR) selective inhibitor class of antibiotics, was specifically designed to address the growing need for additional treatment options to combat resistant infections including MRSA. MRSA affects more than 2 million people in the United States each year and rates of hospital- and community-acquired MRSA are on the rise.(i,ii)

"The high efficacy rates and favorable tolerability profile of iclaprim strongly supports its potential as a new treatment option for patients who have acquired serious infections caused by MRSA," said Dennis L. Stevens, MD, PhD, Veterans Affairs Medical Center, Boise, Idaho. "With rates of MRSA increasing and effectiveness of some current antibiotics declining, it is important to identify effective alternative treatments for these infections."

The results presented at the ICAA
'/>"/>

SOURCE Arpida
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
4. Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint
5. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
6. CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation
7. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
8. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
9. Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
10. Interim Response and Safety Analyses Support Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma
11. Arbios Provides Clinical Strategy for SEPET(TM) Pivotal Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 Research and ... "Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014" ... conventional methods developed to prevent and eradicate the prevalence ... These methods are confined to low specificity, safety and ... to look for a better solution. It has been ...
(Date:8/29/2014)... Aug. 29, 2014 Research and Markets ... and Development Trend Forecast of Pharmaceutical Equipment Market in ... Research and Development Trend Forecast of Pharmaceutical Equipment ... analyzes China,s pharmaceutical equipment industry ... demand, competition landscape, and business performance of domestic major ...
(Date:8/29/2014)... Diseases largely eradicated in the ... Measles was declared eliminated in 2000, yet the CDC ... 15—the highest incidence in 20 years. In July, ... cough a problem of "epidemic proportions." ... from these preventable diseases—in part because some parents (more ...
Breaking Medicine Technology:Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014 2Research and Development Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3
... , LAUSANNE, Switzerland, October 15 ... low-cost, integrated molecular and,immunodiagnostics based on its proprietary micro-technology ... equity financing round. The,Company raised EUR 10 million ( ... investors. , The deal was ...
... Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the ... http://www.cordblood-america.com ) focused on bringing the life ... for families nationwide and internationally, today addressed shareholder questions ... interview of Matthew Schissler, founder and CEO, by analyst ...
Cached Medicine Technology:Biocartis Raises EUR10 Million in Series A Financing Round 2Biocartis Raises EUR10 Million in Series A Financing Round 3Cord Blood America Details Las Vegas Laboratory Progress in Analyst Interview 2Cord Blood America Details Las Vegas Laboratory Progress in Analyst Interview 3
(Date:8/30/2014)... Barcelona, Spain Saturday 30 August 2014: The ... oral anticoagulants in pulmonary embolism are published today ... at ESC Congress by Professor Stavros V. Konstantinides ... "2014 ESC Guidelines on the diagnosis and management ... in European Heart Journal (1) and on the ...
(Date:8/29/2014)... 30, 2014 Indosoft, Inc. , ... announces the release of its most advanced contact center ... of new features as well as updates to existing ... , Q-Suite functionality on the presentation side has received ... into the script builder. This WYSIWYG editor allows ...
(Date:8/29/2014)... 29, 2014 According to the latest review ... to lose weight quickly, safely and naturally. The new method ... be amazingly fast, too. , Daily Gossip writes in ... not only teach patients how to eliminate the extra pounds, ... results when it comes to body modeling. , The ...
(Date:8/29/2014)... The new review that can be read on ... system that will permanently eliminate the symptoms of this disease. ... achieve a cure in as fast as 30 to 60 ... about one week. , The Tinnitus Miracle review indicates ... mild hearing loss, pain in the ear and dizziness. Read ...
(Date:8/29/2014)... August 29, 2014 Panic attacks are ... the feeling of intense stress and fear, which appears ... the sufferer, causing insecurity and affecting relationships. , A ... there are many symptoms that patients can deal with. ... these symptoms. Overcoming panic attacks is extremely important for ...
Breaking Medicine News(10 mins):Health News:First recommendations on all new oral anticoagulants in pulmonary embolism published 2Health News:Indosoft Releases Q-Suite 5.7.7 2Health News:Flat Belly Forever Review Exposes the Way to Eliminate Body Fat Easily 2Health News:Tinnitus Miracle Review Reveals How to Gain Tinnitus Relief in 7 Days 2Health News:60 Second Panic Solution Review Exposes Simple Panic Attacks Remedy 2
... 4 (HealthDay News) -- Rates of head and neck cancer ... without any known risk factors. Now, a study suggests that ... of precancerous cells in the mouth. Previous research ... the lungs are exposed to smoke. This may lead to ...
... study of its kind, a research team led by Michigan ... the most traumatic situations were less likely to suffer health ... surveyed Army troops fighting in Iraq, could have implications for ... events such as death. Training these first-responders to think in ...
... (RA) who are current smokers were less likely to achieve ... inhibitors than those who never smoked. The study by researchers ... the past did not experience a lower response to these ... 2011 issue of Arthritis & Rheumatism , a journal ...
... Amanda Gardner HealthDay Reporter , MONDAY, Jan. 3 ... cancer on the left side of the colon, new research ... right side. The finding contradicts some previous research that ... However, the right-side benefit shown in the new study, published ...
... FOR MODERATE TO SEVERE ASTHMA ... is safe and effective an add-on treatment to corticosteroids for ... Uruguay, Argentina, and Chile performed a meta-analysis on eight trials ... At the end of the steroid reduction phase, patients taking ...
... The rapid growth in use of medical diagnostic imaging, ... radiation exposure in adults and the potential for future cancer ... led by University of Michigan researchers now shows that kids ... routine clinical care, and highlights the importance of initiatives to ...
Cached Medicine News:Health News:Estrogen May Play Role in Rising Rates of Head, Neck Cancer 2Health News:MSU leads first study of resiliency on the battlefield 2Health News:Current smokers with early rheumatoid arthritis less responsive to TNF inhibitors, methotrexate 2Health News:Colonoscopies May Not Have 'Blind Spot' After All 2Health News:Colonoscopies May Not Have 'Blind Spot' After All 3Health News:News briefs from the January issue of Chest 2Health News:U-M study: Kids frequently exposed to medical imaging procedures that use radiation 2Health News:U-M study: Kids frequently exposed to medical imaging procedures that use radiation 3
Shandon Laser MicroWriter is a laser labeling system developed specifically for anatomical pathology....
Modular Slide Storage Cabinet has a durable cold rolled steel construction with baked on epoxy finish. Drawers slide smoothly and quietly....
Store microscope slides with ease, speed, efficiency....
... offers special drawers for just about everything imaginable ... microscopy laboratory. Each box is designed for long ... the advantages of wood over metal systems is ... as a subtle kind of desiccator and insulator, ...
Medicine Products: